CLINICAL_TRIALS
trial_result
· 2015-10-19
Clinical Trial Update: A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP) [Phase 4]
Summary
A Phase 4 safety study evaluating intravenous immunoglobulin in patients with Immune Thrombocytopenic Purpura has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CSL Behring | Conditions: Immune Thrombocytopenic Purpura | Phase 4 | Status: COMPLETED | Results posted: 2015-10-19